You begin with 270 bones at birth which drops down to 206 during adult-hood.
Answer:
I think not
Explanation:
The first thing you have to do is define what is scarcity and what is a shortage. Off the top of my head scarcity is when a resource is available in a finite quantity but on the other hand a shortage is when a popular product or resource is easy to get but supply doesn't satisfy the demand. So in lame mans terms
scarcity = When you dont have much of a resource at all
Shortage =You have the resource readily available but sometimes the supply doesn't meet the demand thus a temporary drop in the resource you want or need.
HOPE THIS HELPED :)
l
I believe protecting your hands.
Answer:
Docking sites for EGFR target proteins are not generated inside the cell
Explanation:
The epidermal growth factor receptor (EGFR; ErbB-1; HER1 in humans) is a transmembrane protein that is a receptor for members of the epidermal growth factor family (EGF family) of extracellular proteins ligands.
The epidermal growth factor receptor is a member of the ErbB family of receptors, a subfamily of four closely related receptor tyrosine kinases: EGFR (ErbB-1), HER2/neu (ErbB-2), Her 3 (ErbB-3) and Her 4 (ErbB-4). In many cancer types, mutations affecting EGFR expression or activity could result in cancer.
Epidermal growth factor and its receptor was discovered by Stanley Cohen of Vanderbilt University. Cohen shared the 1986 Nobel Prize in Medicine with Rita Levi-Montalcini for their discovery of growth factors.
Deficient signaling of the EGFR and other receptor tyrosine kinases in humans is associated with diseases such as Alzheimer's, while over-expression is associated with the development of a wide variety of tumors. Interruption of EGFR signalling, either by blocking EGFR binding sites on the extracellular tyrosine kinase activity, can prevent the growth of EGFR-expressing tumors and improve the patient's condition.
